Company research
Rich Pharmaceuticals, Inc.
CIK 1504389Updated Sep 27, 2026
Securities
Historical securities (1)
RCHA · NASDAQ · equity · closed Oct 29, 2021Name history
Nepia Inc. · through Aug 19, 2013
RCHA price & chart
Historical security
This listing closed Oct 29, 2021. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2018 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 37,429Source | 53,028Source | 6,531Source | 24,258Source |
| Property, Plant and Equipment, NetUSD | 913Source | 2,125Source | 3,731Source | 788Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 6,222Source | 40,903Source | — | 15,892Source |
| Assets, CurrentUSD | 24,516Source | 50,903Source | 2,800Source | 23,470Source |
| Prepaid Expense and Other Assets, CurrentUSD | — | — | 2,800Source | 7,578Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 6,396,089Source | 5,378,847Source | 2,398,233Source | 1,743,199Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 6,000Source | 6,000Source | 6,000Source | 6,000Source |
| Common Stock, Value, IssuedUSD | 1,709,058Source | 101,446Source | 216,364Source | 1,541,083Source |
| Additional Paid in CapitalUSD | 5,963,392Source | 7,011,504Source | 6,589,374Source | 4,168,956Source |
| Retained Earnings (Accumulated Deficit)USD | -14,137,110Source | -12,444,769Source | -9,203,440Source | -7,434,980Source |
| Stockholders' Equity Attributable to ParentUSD | -6,358,660Source | -5,325,819Source | -2,391,702Source | -1,718,941Source |
| Liabilities and EquityUSD | 37,429Source | 53,028Source | 6,531Source | 24,258Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 6,396,089Source | 5,378,847Source | 2,398,233Source | 1,659,344Source |
| Accounts Payable, CurrentUSD | 327,146Source | 349,635Source | 1,139,431Source | 910,272Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 1,844,207Source | 937,783Source | 530,150Source | 200,891Source |
| Long-term Debt, Current MaturitiesUSD | 900,000Source | 920,000Source | — | — |
cash flow · annual statements
| Line item | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | 48,016Source | 240,999Source | 866,128Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | 371,464Source | 110,204Source | 229,159Source | 729,600Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -508,479Source | -553,394Source | -495,099Source | -1,445,068Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -17,300Source | -10,000Source | -3,741Source | 0Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | 0Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 491,098Source | 604,297Source | 482,948Source | 1,448,573Source |
| Additional Financial Items | ||||
| Debt Securities, Realized Gain (Loss)USD | 52,000Source | — | — | — |
| DepreciationUSD | 1,212Source | 1,606Source | 799Source | 473Source |
| Gain (Loss) on Extinguishment of DebtUSD | -213,294Source | 70,477Source | — | 6,009Source |
| Net Income (Loss) Attributable to ParentUSD | -1,692,341Source | -3,241,329Source | -1,768,460Source | -4,133,576Source |
| Nonoperating Income (Expense)USD | -355,953Source | — | — | — |
| Operating Costs and ExpensesUSD | 177,483Source | 123,619Source | 110,600Source | 97,821Source |
| Operating ExpensesUSD | 1,451,388Source | 951,817Source | 1,117,605Source | 3,606,425Source |
income statement · annual statements
| Line item | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Total RevenueUSD | 115,000Source | — | — | 0Source |
| Operating Income (Loss)USD | -1,336,388Source | -951,817Source | -1,117,605Source | -3,606,425Source |
| Net Income (Loss) Attributable to ParentUSD | -1,692,341Source | -3,241,329Source | -1,768,460Source | -4,133,576Source |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | — | — | — | 0Source |
| Debt Securities, Realized Gain (Loss)USD | 52,000Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -1,692,341Source | -3,241,329Source | -1,768,460Source | -4,133,576Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | — | 30,000Source |
| Interest ExpenseUSD | -663,633Source | -224,828Source | -185,136Source | -56,531Source |
| Labor and Related ExpenseUSD | 555,414Source | 362,626Source | 383,937Source | 727,458Source |
| Nonoperating Income (Expense)USD | -355,953Source | — | — | — |
| Operating Costs and ExpensesUSD | 177,483Source | 123,619Source | 110,600Source | 97,821Source |
| Operating ExpensesUSD | 1,451,388Source | 951,817Source | 1,117,605Source | 3,606,425Source |
| Other ExpensesUSD | — | -2,289,512Source | -650,855Source | 527,151Source |
| Research and Development ExpenseUSD | 332,634Source | 71,930Source | 16,823Source | 165,371Source |